RENB Renovaro

Watchlist

0.894
-0.089-9.05%

Close Mar 3 16:00 ET

0.880
-0.014-1.52%

Pre 05:47 ET

141.85MMarket Cap-1.15P/E (TTM)

About Renovaro Company

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Company Profile

SymbolRENB

Company NameRenovaro

Listing DateDec 10, 2018

Founded2011

CEOMr. David Weinstein

MarketNASDAQ

Employees25

Fiscal Year Ends06-30

Address2080 Century Park East,Suite 906

CityLos Angeles

ProvinceCalifornia

CountryUnited States of America

Zip Code90067

Phone1-305-918-1980

Websitehttp://renovarobio.com

Company Executives

Name
Position
Salary

David Weinstein
Chief Executive Officer and Director
--

Maurice van Tilburg
Director; Chief Executive Officer, GEDi Cube B.V
--

Nathen Fuentes, C.P.A.
Chief Financial Officer
--

Dr. Mark A. Collins, PhD
Director
--

Douglas W. Calder
Director
--

James A. Mcnulty, C.P.A.
Director
--

RENB Renovaro

About Renovaro Company

Company Profile

Company Executives

Trending Stocks